Isoliquiritin apioside |
Catalog No.GC39095 |
Isoliquiritin apioside는 MMP9 활성의 PMA 유도 증가를 유의하게 감소시키고 PMA 유도 MAPK 및 NF-κB 활성화를 억제합니다. Isoliquiritin apioside는 암세포와 내피세포의 침습성과 혈관신생을 억제합니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 120926-46-7
Sample solution is provided at 25 µL, 10mM.
Isoliquiritin apioside, a component isolated from Glycyrrhizae radix rhizome, significantly decreases PMA-induced increases in MMP9 activities and suppresses PMA-induced activation of MAPK and NF-κB. Isoliquiritin apioside auppresseses invasiveness and angiogenesis of cancer cells and endothelial cells[1].
[1]. Kim A1, et al. Isoliquiritin Apioside Suppresses in vitro Invasiveness and Angiogenesis of Cancer Cells and Endothelial Cells.Front Pharmacol. 2018 Dec 10;9:1455.
Average Rating: 5
(Based on Reviews and 38 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *